Demant Total Assets 2012-2024 | WILYY
- Demant total assets for the quarter ending December 31, 2024 were $4.705B, a 20.37% increase year-over-year.
- Demant total assets for 2024 were $4.705B, a 6.09% increase from 2023.
- Demant total assets for 2023 were $4.435B, a 4.91% increase from 2022.
- Demant total assets for 2022 were $4.228B, a 6.89% increase from 2021.
Demant Annual Total Assets (Millions of US $) |
|
---|---|
2024 | $4,705 |
2023 | $4,435 |
2022 | $4,228 |
2021 | $3,955 |
2020 | $3,359 |
2019 | $3,268 |
2018 | $2,841 |
2017 | $2,464 |
2016 | $2,310 |
2015 | $2,142 |
2014 | $0 |
2013 | $1,845 |
2012 | $1,517 |
2011 | $1,429 |
Demant Quarterly Total Assets (Millions of US $) |
|
---|---|
2024-12-31 | $4,705 |
2023-12-31 | $4,435 |
2023-06-30 | $4,359 |
2022-12-31 | $4,228 |
2022-06-30 | $3,909 |
2021-12-31 | $3,955 |
2021-06-30 | $3,822 |
2020-12-31 | $3,359 |
2020-06-30 | $3,259 |
2019-12-31 | $3,268 |
2019-06-30 | $3,126 |
2018-12-31 | $2,841 |
2018-06-30 | $2,758 |
2017-12-31 | $2,464 |
2017-06-30 | $2,379 |
2016-12-31 | $2,310 |
2016-06-30 | $2,270 |
2015-12-31 | $2,142 |
2014-06-30 | $1,972 |
2013-12-31 | $1,845 |
2013-06-30 | $1,725 |
2012-12-31 | $1,517 |
2012-06-30 | $1,402 |
2011-12-31 | $1,429 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $9.110B | $3.252B |
Demant A/S is engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company's business area consists of Hearing Devices, Hearing Implants, Diagnostic Instruments and Personal Communication. Demant A/S, formerly known as William Demant Holding A/S, is based in Smorum, Denmark. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $231.851B | 27.88 |
Boston Scientific (BSX) | United States | $151.436B | 37.91 |
Stryker (SYK) | United States | $144.721B | 30.26 |
EssilorLuxottica (ESLOY) | France | $129.653B | 0.00 |
Medtronic (MDT) | Ireland | $110.247B | 15.63 |
Lonza Group Ag (LZAGY) | Switzerland | $50.183B | 0.00 |
Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
ResMed (RMD) | United States | $37.320B | 28.03 |
Agilent Technologies (A) | United States | $32.988B | 21.51 |
GE HealthCare Technologies (GEHC) | United States | $32.583B | 15.47 |
Terumo (TRUMY) | Japan | $26.976B | 35.04 |
Koninklijke Philips (PHG) | Netherlands | $21.839B | 15.32 |
Insulet (PODD) | United States | $21.652B | 84.99 |
Zimmer Biomet Holdings (ZBH) | United States | $18.103B | 11.63 |
Baxter (BAX) | United States | $15.390B | 11.49 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.776B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.410B | 22.31 |
Lantheus Holdings (LNTH) | United States | $5.591B | 14.10 |
Prestige Consumer Healthcare (PBH) | United States | $4.170B | 18.63 |
Perrigo (PRGO) | Ireland | $3.636B | 9.22 |
Haemonetics (HAE) | United States | $3.462B | 15.77 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.203B | 26.62 |
ICU Medical (ICUI) | United States | $3.152B | 23.24 |
GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
LeMaitre Vascular (LMAT) | United States | $1.884B | 42.11 |
QuidelOrtho (QDEL) | United States | $1.870B | 12.86 |
AtriCure (ATRC) | United States | $1.579B | 0.00 |
Acuren (TIC) | United States | $1.283B | 0.00 |
AdaptHealth (AHCO) | United States | $1.120B | 11.37 |
Neogen (NEOG) | United States | $1.035B | 13.25 |
Green Thumb Industries (GTBIF) | United States | $1.018B | 22.91 |
BioLife Solutions (BLFS) | United States | $1.015B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
InMode (INMD) | Israel | $0.853B | 8.59 |
Kestra Medical Technologies (KMTS) | United States | $0.822B | 0.00 |
CeriBell (CBLL) | United States | $0.668B | 0.00 |
Evolus (EOLS) | United States | $0.605B | 0.00 |
Owens & Minor (OMI) | United States | $0.562B | 4.67 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.537B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.514B | 0.00 |
Valneva SE (VALN) | France | $0.476B | 0.00 |
Surmodics (SRDX) | United States | $0.415B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.363B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
SNDL (SNDL) | Canada | $0.326B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.323B | 11.86 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.287B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
Cerus (CERS) | United States | $0.256B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
Quanterix (QTRX) | United States | $0.245B | 0.00 |
ZimVie (ZIMV) | United States | $0.241B | 10.95 |
OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.222B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.220B | 65.17 |
Biote (BTMD) | United States | $0.219B | 6.17 |
Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
Brainsway (BWAY) | Israel | $0.217B | 57.45 |
TriSalus Life Sciences (TLSI) | United States | $0.200B | 0.00 |
Omeros (OMER) | United States | $0.187B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.178B | 14.52 |
Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
High Tide (HITI) | Canada | $0.175B | 0.00 |
Organigram Global (OGI) | Canada | $0.171B | 0.00 |
Exagen (XGN) | United States | $0.148B | 0.00 |
Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
FitLife Brands (FTLF) | United States | $0.122B | 15.02 |
Jin Medical (ZJYL) | China | $0.101B | 0.00 |
Veru (VERU) | United States | $0.091B | 0.00 |
Fonar (FONR) | United States | $0.088B | 11.29 |
Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
MacroGenics (MGNX) | United States | $0.083B | 0.00 |
Cytosorbents (CTSO) | United States | $0.079B | 0.00 |
Apyx Medical (APYX) | United States | $0.076B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.076B | 0.00 |
Zynex (ZYXI) | United States | $0.072B | 0.00 |
InterCure (INCR) | Israel | $0.071B | 0.00 |
Agape ATP (ATPC) | $0.069B | 0.00 | |
ImmuCell (ICCC) | United States | $0.060B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
Nephros (NEPH) | United States | $0.045B | 61.29 |
Modular Medical (MODD) | United States | $0.042B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 13.03 |
Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
Safety Shot (SHOT) | United States | $0.025B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
INLIF (INLF) | $0.017B | 0.00 | |
Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
Senestech (SNES) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |